Heal WP, Wickramasinghe SR, Bowyer PW, Holder AA, Smith DF, Leatherbarrow RJ, Tate EW (2008). "Site-specific N-terminal labelling of proteins in vitro and in vivo using N-myristoyl transferase and bioorthogonal ligation chemistry". Chem. Commun. (Camb.) (4): 480. PMID18188474. doi:10.1039/b716115h.
Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, Varhaug JE, Vandekerckhove J, Lillehaug JR, Sherman F, Gevaert K (2009). "Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans". Proc. Natl. Acad. Sci. U.S.A.106 (20): 8157–8162. Bibcode:2009PNAS..106.8157A. PMID19420222. doi:10.1073/pnas.0901931106.
Hollebeke J, Van Damme P, Gevaert K (2012). "N-terminal acetylation and other functions of Nα-acetyltransferases". Biol. Chem.393 (4): 291–8. PMID22718636. doi:10.1515/hsz-2011-0228.
Behnia R, Panic B, Whyte JR, Munro S (2004). "Targeting of the Arf-like GTPase Arl3p to the Golgi requires N-terminal acetylation and the membrane protein Sys1p". Nat. Cell Biol.6 (5): 405–413. PMID15077113. doi:10.1038/ncb1120.
Gromyko D, Arnesen T, Ryningen A, Varhaug JE, Lillehaug JR (2010). "Depletion of the human Nα-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition". Int. J. Cancer127 (12): 2777–2789. PMID21351257. doi:10.1002/ijc.25275.
Kamita M, Kimura Y, Ino Y, Kamp RM, Polevoda B, Sherman F, Hirano H (2011). "N(α)-Acetylation of yeast ribosomal proteins and its effect on protein synthesis". J Proteomics74 (4): 431–441. PMID21184851. doi:10.1016/j.jprot.2010.12.007.
Yu M, Gong J, Ma M, Yang H, Lai J, Wu H, Li L, Li L, Tan D (2009). "Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo". Oncol. Rep.21 (4): 909–15. PMID19287988. doi:10.3892/or_00000303.
Kalvik TV, Arnesen T (2013). "Protein N-terminal acetyltransferases in cancer". Oncogene32 (3): 269–276. PMID22391571. doi:10.1038/onc.2012.82.
Sadoul K, Boyault C, Pabion M, Khochbin S (2008). "Regulation of protein turnover by acetyltransferases and deacetylases". Biochimie90 (2): 306–12. PMID17681659. doi:10.1016/j.biochi.2007.06.009.
Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene363: 15–23. PMID16289629. doi:10.1016/j.gene.2005.09.010.
Brooks CL, Gu W (2011). "The impact of acetylation and deacetylation on the p53 pathway". Protein Cell2 (6): 456–462. PMID21748595. doi:10.1007/s13238-011-1063-9.
Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004). "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2". Science303 (5659): 844–848. Bibcode:2004Sci...303..844V. PMID14704432. doi:10.1126/science.1092472.
Friedmann DR, Aguilar A, Fan J, Nachury MV, Marmorstein R (2012). "Structure of the α-tubulin acetyltransferase, αTAT1, and implications for tubulin-specific acetylation". Proc. Natl. Acad. Sci. U.S.A.109 (48): 19655–19660. Bibcode:2012PNAS..10919655F. PMID23071314. doi:10.1073/pnas.1209357109.
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP (2002). "HDAC6 is a microtubule-associated deacetylase". Nature417 (6887): 455–458. Bibcode:2002Natur.417..455H. PMID12024216. doi:10.1038/417455a.
Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DS, Forman SJ, Jove R, Riggs AD, Yu H (2012). "Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation". Proc. Natl. Acad. Sci. U.S.A.109 (20): 7765–7769. Bibcode:2012PNAS..109.7765L. PMID22547799. doi:10.1073/pnas.1205132109.
harvard.edu
adsabs.harvard.edu
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science325 (5942): 834–840. Bibcode:2009Sci...325..834C. PMID19608861. doi:10.1126/science.1175371.
Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, Varhaug JE, Vandekerckhove J, Lillehaug JR, Sherman F, Gevaert K (2009). "Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans". Proc. Natl. Acad. Sci. U.S.A.106 (20): 8157–8162. Bibcode:2009PNAS..106.8157A. PMID19420222. doi:10.1073/pnas.0901931106.
Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004). "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2". Science303 (5659): 844–848. Bibcode:2004Sci...303..844V. PMID14704432. doi:10.1126/science.1092472.
Friedmann DR, Aguilar A, Fan J, Nachury MV, Marmorstein R (2012). "Structure of the α-tubulin acetyltransferase, αTAT1, and implications for tubulin-specific acetylation". Proc. Natl. Acad. Sci. U.S.A.109 (48): 19655–19660. Bibcode:2012PNAS..10919655F. PMID23071314. doi:10.1073/pnas.1209357109.
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP (2002). "HDAC6 is a microtubule-associated deacetylase". Nature417 (6887): 455–458. Bibcode:2002Natur.417..455H. PMID12024216. doi:10.1038/417455a.
Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DS, Forman SJ, Jove R, Riggs AD, Yu H (2012). "Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation". Proc. Natl. Acad. Sci. U.S.A.109 (20): 7765–7769. Bibcode:2012PNAS..109.7765L. PMID22547799. doi:10.1073/pnas.1205132109.
nih.gov
ncbi.nlm.nih.gov
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science325 (5942): 834–840. Bibcode:2009Sci...325..834C. PMID19608861. doi:10.1126/science.1175371.
Heal WP, Wickramasinghe SR, Bowyer PW, Holder AA, Smith DF, Leatherbarrow RJ, Tate EW (2008). "Site-specific N-terminal labelling of proteins in vitro and in vivo using N-myristoyl transferase and bioorthogonal ligation chemistry". Chem. Commun. (Camb.) (4): 480. PMID18188474. doi:10.1039/b716115h.
Arnesen T, Van Damme P, Polevoda B, Helsens K, Evjenth R, Colaert N, Varhaug JE, Vandekerckhove J, Lillehaug JR, Sherman F, Gevaert K (2009). "Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans". Proc. Natl. Acad. Sci. U.S.A.106 (20): 8157–8162. Bibcode:2009PNAS..106.8157A. PMID19420222. doi:10.1073/pnas.0901931106.
Hollebeke J, Van Damme P, Gevaert K (2012). "N-terminal acetylation and other functions of Nα-acetyltransferases". Biol. Chem.393 (4): 291–8. PMID22718636. doi:10.1515/hsz-2011-0228.
Behnia R, Panic B, Whyte JR, Munro S (2004). "Targeting of the Arf-like GTPase Arl3p to the Golgi requires N-terminal acetylation and the membrane protein Sys1p". Nat. Cell Biol.6 (5): 405–413. PMID15077113. doi:10.1038/ncb1120.
Gromyko D, Arnesen T, Ryningen A, Varhaug JE, Lillehaug JR (2010). "Depletion of the human Nα-terminal acetyltransferase A induces p53-dependent apoptosis and p53-independent growth inhibition". Int. J. Cancer127 (12): 2777–2789. PMID21351257. doi:10.1002/ijc.25275.
Kamita M, Kimura Y, Ino Y, Kamp RM, Polevoda B, Sherman F, Hirano H (2011). "N(α)-Acetylation of yeast ribosomal proteins and its effect on protein synthesis". J Proteomics74 (4): 431–441. PMID21184851. doi:10.1016/j.jprot.2010.12.007.
Yu M, Gong J, Ma M, Yang H, Lai J, Wu H, Li L, Li L, Tan D (2009). "Immunohistochemical analysis of human arrest-defective-1 expressed in cancers in vivo". Oncol. Rep.21 (4): 909–15. PMID19287988. doi:10.3892/or_00000303.
Kalvik TV, Arnesen T (2013). "Protein N-terminal acetyltransferases in cancer". Oncogene32 (3): 269–276. PMID22391571. doi:10.1038/onc.2012.82.
Sadoul K, Boyault C, Pabion M, Khochbin S (2008). "Regulation of protein turnover by acetyltransferases and deacetylases". Biochimie90 (2): 306–12. PMID17681659. doi:10.1016/j.biochi.2007.06.009.
Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene363: 15–23. PMID16289629. doi:10.1016/j.gene.2005.09.010.
Brooks CL, Gu W (2011). "The impact of acetylation and deacetylation on the p53 pathway". Protein Cell2 (6): 456–462. PMID21748595. doi:10.1007/s13238-011-1063-9.
Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004). "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2". Science303 (5659): 844–848. Bibcode:2004Sci...303..844V. PMID14704432. doi:10.1126/science.1092472.
Friedmann DR, Aguilar A, Fan J, Nachury MV, Marmorstein R (2012). "Structure of the α-tubulin acetyltransferase, αTAT1, and implications for tubulin-specific acetylation". Proc. Natl. Acad. Sci. U.S.A.109 (48): 19655–19660. Bibcode:2012PNAS..10919655F. PMID23071314. doi:10.1073/pnas.1209357109.
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP (2002). "HDAC6 is a microtubule-associated deacetylase". Nature417 (6887): 455–458. Bibcode:2002Natur.417..455H. PMID12024216. doi:10.1038/417455a.
Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DS, Forman SJ, Jove R, Riggs AD, Yu H (2012). "Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation". Proc. Natl. Acad. Sci. U.S.A.109 (20): 7765–7769. Bibcode:2012PNAS..109.7765L. PMID22547799. doi:10.1073/pnas.1205132109.